BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15229149)

  • 1. Differentiation of acute myeloid leukemia from B- and T-lineage acute lymphoid leukemias by real-time quantitative reverse transcription-PCR of lineage marker mRNAs.
    Saussoy P; Vaerman JL; Straetmans N; Deneys V; Cornu G; Ferrant A; Latinne D
    Clin Chem; 2004 Jul; 50(7):1165-73. PubMed ID: 15229149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.
    Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B
    Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
    Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens.
    Arber DA; Jenkins KA
    Am J Clin Pathol; 1996 Oct; 106(4):462-8. PubMed ID: 8853033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols.
    Kappelmayer J; Gratama JW; Karászi E; Menéndez P; Ciudad J; Rivas R; Orfao A
    J Immunol Methods; 2000 Aug; 242(1-2):53-65. PubMed ID: 10986389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage.
    Frater JL; Yaseen NR; Peterson LC; Tallman MS; Goolsby CL
    Arch Pathol Lab Med; 2003 Mar; 127(3):356-9. PubMed ID: 12653584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny.
    Dworzak MN; Fritsch G; Fröschl G; Printz D; Gadner H
    Blood; 1998 Nov; 92(9):3203-9. PubMed ID: 9787156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of lineage markers using real-time quantitative polymerase chain reaction (RT-qPCR) in normal and in leukemia bone marrow.
    Saussoy P; Vaerman JL; Druez V; Deneys V; Straetmans N; Cornu G; Ferrant A; Latinne D
    Clin Chem Lab Med; 2009; 47(4):419-26. PubMed ID: 19327122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of myeloperoxidase by flow cytometry in acute leukemia.
    Nakase K; Sartor M; Bradstock
    Cytometry; 1998 Aug; 34(4):198-202. PubMed ID: 9725460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
    Naghashpour M; Lancet J; Moscinski L; Zhang L
    Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
    Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
    Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
    Traweek ST; Liu J; Braziel RM; Johnson RM; Byrnes RK
    Diagn Mol Pathol; 1995 Sep; 4(3):212-9. PubMed ID: 7493141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric detection of cytoplasmic antigens in acute leukemias: implications for lineage assignment.
    Drach D; Drach J; Glassl H; Gattringer C; Huber H
    Leuk Res; 1993 May; 17(5):455-61. PubMed ID: 8388970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
    Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
    Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
    Crisan D; David D; DiCarlo R
    Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.